Document:

<PAGE>

                                                                    EXHIBIT 10.6

                 FORM OF NON -QUALIFIED STOCK OPTION AGREEMENT

                                          UK/EMPLOYEE NON-QUALIFIED STOCK OPTION
                                                            (AS AMENDED 4/22/04)

                            OSI PHARMACEUTICALS, INC.

                              AMENDED AND RESTATED
                              STOCK INCENTIVE PLAN

      THIS NON-QUALIFIED STOCK OPTION is granted as of {DATE OF GRANT}, by OSI
PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), to {FIRST NAME
LAST NAME} (the "Optionee"), an employee of the Company. The Option is granted
subject to a condition that any liability of [Prosidion Limited or OSI
Pharmaceuticals (UK) Limited] ("the UK Subsidiary") (as employer or former
employer of the Optionee) to pay secondary national insurance contributions
("Secondary NIC") in respect of the exercise, assignment or release of the
Option shall be the liability of the Optionee and payable by the Optionee and
that the Optionee shall be required to enter into an election in the form
envisaged in Paragraph 313(1) of Schedule 1 to the Social Security Contributions
and Benefits Act 1992 ("Election") to that effect when required to do so by the
UK Subsidiary provided that the Committee may in its discretion at any time or
times release the Optionee from this liability or reduce his liability
thereunder unless that Election has been entered into between the UK Subsidiary
and the Optionee and that Election (or the legislation which provides for such
an Election to be effective) does not allow for such an Election to be
subsequently varied. For the avoidance of doubt the terms of the Election shall
include a statement to the effect that the Optionee is liable to pay any
Secondary NIC arising on the exercise of the Option even if he is no longer an
employee of the UK Subsidiary and/or no longer resident in the United Kingdom at
the date of exercise.

      Pursuant to the OSI Pharmaceuticals, Inc. Amended and Restated Stock
Incentive Plan (the "Plan"), a copy of which has been provided to Optionee as of
the date hereof, the Optionee was granted a non-qualified stock option to
purchase shares of the Company's common stock, par value $.01 per share (the
"Common Stock"), as hereinafter set forth. The option granted herein is not
intended to qualify as an "incentive stock option" as defined in Section 422 of
the Internal Revenue Code of 1986, as amended.

                              W I T N E S S E T H:

      1. Grant. Effective as of {GRANT DATE} (the "Date of Grant"), the Company
granted to the Optionee an option (the "Option") to purchase on the terms and
conditions set forth herein and in the Plan all or any part of an aggregate of
{OPTION AMOUNT} shares of Common Stock (the "Option Shares"), at the purchase
price of {$PRICE} per share (the "Option Price").

      2. Vesting. The Optionee shall have the cumulative right to exercise the
Option, and the Option is only exercisable, as follows:

<PAGE>

            a. The Option shall not be exercisable prior to the first annual
anniversary of the Date of Grant (the "First Anniversary");

            b. Beginning on the First Anniversary, one third of the Option
Shares shall become exercisable, with any fractional number of Option Shares
that would otherwise become exercisable as of that date rounded to a whole
integer as determined in the discretion of the Committee.

            c. The remaining two-thirds of the Option Shares shall become
exercisable ratably as of each monthly anniversary of the Date of Grant
beginning with the 12th monthly anniversary of the Date of Grant and ending on
the 36th monthly anniversary of the Date of Grant, with any fractional number of
Option Shares that would otherwise become exercisable as of any such monthly
anniversary rounded to a whole integer as determined in the discretion of the
Committee.

      3. Term. The Option shall terminate in all events at 5:00 p.m. (local New
York, New York time) on {DAY BEFORE GRANT DATE + 10 YEARS} (the "Termination
Date"), unless sooner terminated as provided in Subparagraphs (a) or (b) below.

            a. Termination of Employment or Service. The Option shall terminate
and shall no longer be exercisable ninety (90) days after the Optionee's
employment (or service as an officer or consultant) with the Company and any
parent or subsidiary of the Company terminates, unless such termination of
employment or service was caused by the Optionee's death or Retirement (as
defined in the Plan). The death or Retirement of the Optionee shall not affect
the remaining term of the Option. Following a termination of employment or
service, the Optionee (or the Optionee's heirs or personal representatives if
Optionee is deceased) may, during the remaining term of the Option, purchase any
remaining Option Shares which could have been purchased on the date Optionee's
employment or service was terminated, but may not purchase any Option Shares
which would otherwise have first become purchasable following such termination
of employment or service.

            b. Sale or Reorganization. As provided in Section 6(i) of the Plan,
if the Company is merged or consolidated with another corporation, or if the
property or stock of the Company is acquired by another corporation, or if there
is a separation, reorganization or liquidation of the Company, the Board of
Directors of the Company may, in its discretion, give Optionee a written notice
that the Option will terminate thirty (30) days after the date of such written
notice. In any such case, the Option will become immediately exercisable in
full, notwithstanding Paragraph 2 above.

      4. Method of Exercise and Payment.

            a. Method of Exercise. Subject to Paragraph 4(d) below, the Option
may be exercised by delivering both to the Company at its principal office,
directed to the attention of the Secretary and to the UK Subsidiary (as the
employer or former employer of the Optionee) at its registered office, directed
to the attention of the Finance and Administration Manager, (i) a written notice
of exercise in the form attached hereto as Exhibit "A", signed by the person
entitled to exercise the Option, stating the number of Option Shares such person
then elects to

                                      -2-

<PAGE>

purchase hereunder; (ii) payment of the aggregate Option Price of the Option
Shares being purchased; and (iii) if the Option is being exercised by a person
other than the Optionee, evidence satisfactory to the Company that such person
has a right to exercise the Option. Upon due exercise of the Option and payment
of the Option Price, the Company shall deliver to the Optionee or other person
entitled to exercise the Option a certificate for the Option Shares being
purchased. The Company shall be responsible for any stock transfer tax due upon
the purchase or issuance of the Option Shares.

            b. Medium of Payment. Optionee may pay for Option Shares (i) in
cash, (ii) by certified check payable to the order of the Company, or (iii) by a
combination of the foregoing. Furthermore, subject to the restrictions described
below, payment may be made all or in part in shares of the Common Stock of the
Company held by the Optionee. If payment is made in whole or in part in shares
of Common Stock, then the Optionee shall deliver to the Company certificates
registered in the name of such Optionee representing shares of Common Stock
legally and beneficially owned by such Optionee, free of all liens, claims and
encumbrances of every kind and having a Fair Market Value on the date of
delivery of such Common Stock that is not less than the product of the Option
Price and the number of Option Shares to be purchased with Common Stock,
accompanied by stock powers duly endorsed in blank by the record holder of the
shares represented by such certificates. If payment is made with Common Stock,
the Fair Market Value of such Common Stock shall be determined as provided in
Section 6(k) of the Plan, without regard to the last sentence of such section.
Notwithstanding the foregoing, the Board of Directors, in its sole discretion,
may refuse to accept shares of Common Stock in payment of the Option Price. In
that event, any certificates representing shares of Common Stock which were
delivered to the Company shall be returned to the Optionee with notice of the
refusal of the Board of Directors to accept such shares in payment of the Option
Price.

            c. Taxes. It shall be a condition to the performance of the
Company's obligation to issue or transfer Option Shares upon the exercise of the
Option that the Optionee remit to the Company and/or to any subsidiary being the
employer or former employer of the Optionee an amount sufficient to satisfy any
federal, state and/or local tax withholding requirements arising in connection
with the exercise of the Option or the issuance of Option Shares, other than
stock transfer taxes. If the Company for any reason does not require the
Optionee to make a payment sufficient to satisfy such withholding requirements,
any tax withholding payments made by the Company to any federal, state or local
tax authority with respect to the exercise of the Option shall constitute a
personal obligation of the Optionee to the Company, payable upon demand or, at
the option of the Company, by deduction from future compensation payable to the
Optionee.

            d. National Insurance Contributions. No stock shall be allotted or
transferred to the Optionee by the Company until the UK Subsidiary has received
an amount in cash equal to the amount of the Secondary NIC for which the
Optionee is liable under the terms of the Election ("the NIC Amount"). The
Optionee shall by completing the Election grant to the UK Subsidiary (as
employer or former employer of the Optionee) the irrevocable authority, as agent
of the Optionee and on his behalf, to appoint an Independent Transfer Agent to
act as agent of the Optionholder and on his behalf to sell or procure the sale
of sufficient of the Stock acquired on the exercise, assignment or release of
the Option and remit the net sale proceeds to the UK Subsidiary so that the net
proceeds payable to the UK Subsidiary are so far as possible equal to but not
less than the NIC Amount and the UK Subsidiary shall account to the Optionee for
any

                                      -3-

<PAGE>

balance. In this paragraph 4(d), Independent Transfer Agent means any person
(other than the Company or any company affiliated with the Company or any
individual affiliated with any such company) who is registered as a
broker-dealer with the U.S. Securities and Exchange Commission and who is
thereby able to sell and transfer shares in the Company on behalf of the
Optionee.

            e. Partial Exercise. To the extent otherwise exercisable, the Option
may be exercised in whole or in part, except that the Option may in no event be
exercised with respect to fractional shares.

      5. Transfers. The Option is not transferable by the Optionee otherwise
than by will or pursuant to the laws of descent and distribution in the event of
the Optionee's death, in which event the Option may be exercised by the heirs or
legal representatives of the Optionee. The Option may be exercised during the
lifetime of the Optionee only by the Optionee. Any attempt at assignment,
transfer, pledge or disposition of the Option contrary to the provisions hereof
or the levy of any execution, attachment or similar process upon the Option
shall be null and void and without effect. Any exercise of the Option by a
person other than the Optionee shall be accompanied by appropriate proofs of the
right of such person to exercise the Option.

      6. Adjustments on Changes in Common Stock. In the event that dividends
payable in Common Stock during any fiscal year of the Company exceed in the
aggregate five percent (5%) of the Common Stock issued and outstanding at the
beginning of the year, or in the event there is during any fiscal year of the
Company one or more splits, subdivisions or combinations of shares of Common
Stock resulting in an increase or decrease by more than five percent (5%) of the
shares of Common Stock outstanding at the beginning of the year, the number of
Option Shares deliverable upon the exercise thereafter of the Option shall be
increased or decreased proportionately, as the case may be, without change in
the aggregate purchase price payable upon exercise of the Option. Common Stock
dividends, splits, subdivisions or combinations during any fiscal year which do
not exceed in the aggregate five percent (5%) of the Common Stock issued and
outstanding at the beginning of such year shall not result in any adjustment
under the Option. All adjustments shall be made as of the day such action
necessitating such adjustment becomes effective.

      7. Legal Requirements.

            a. Listing Requirements. If at any time the Board of Directors shall
determine, in its discretion, that the listing, registration, or qualification
of any of the Option Shares upon any securities exchange or under any state or
federal law, or the consent or approval of any governmental regulatory body, is
necessary or desirable as a condition of, or in connection with, the granting of
the Option or the issue, transfer or purchase of Option Shares hereunder, the
Option may not be exercised in whole or in part unless such listing,
registration, qualification, consent, or approval shall have been effected or
obtained free of any conditions not acceptable to the Board of Directors.

            b. Securities Laws. The Company shall not be obligated to sell or
issue any Option Shares in any manner in contravention of the Securities Act of
1933, as amended, or any state securities law. The Board of Directors or the
Committee may, at any time, require, as a

                                      -4-

<PAGE>

condition to the exercise of the Option, the representation or agreement of the
Optionee to the effect that the Option Shares issuable upon exercise of the
Option are acquired by the Optionee for investment purposes and not with a view
to the resale or distribution thereof, and may require such other
representations and documents as may be required to comply with applicable
securities laws.

      8. Administration. The Option has been granted pursuant to, and is subject
to the terms and provisions of, the Plan. All terms used herein which are
defined in the Plan and not otherwise defined herein shall have the same
meanings as in the Plan. To the extent that the provisions hereof conflict with
those of the Plan, the provisions of the Plan shall control. All decisions or
interpretations made by the Committee (as designated under the Plan) regarding
any issue or question arising under the Option or the Plan shall be final,
binding and conclusive on the Company and the Optionee.

      9. Rights as Stockholder. The Optionee shall have none of the rights of a
stockholder with respect to the Option Shares unless and until such Option
Shares shall be issued to the Optionee upon the exercise of the Option. Except
as provided in Paragraph 6 above, no adjustments shall be made for dividends or
other rights for which the record date is prior to the date the stock
certificate is issued.

      10. Continued Employment or Service. Nothing contained herein or in the
Plan shall confer any right to continue in the employ or service of the Company
or any parent or subsidiary of the Company or interfere in any way with the
right of the Company or any parent or subsidiary of the Company to terminate the
employment, services, responsibilities or duties of the Optionee at any time for
any reason whatsoever.

      11. Sale of Option Shares. Unless otherwise provided by the Committee, no
Option Shares acquired upon exercise of the Option may be sold or otherwise
disposed of by the Optionee within six months from the Date of Grant.

      12. Notices. Any notice to be given to the Company hereunder shall be
delivered personally to the Secretary of the Company or mailed or delivered to
the Company at its principal executive office, addressed to the attention of the
Secretary, and any notice to be given to the Optionee hereunder shall be
delivered personally or mailed or delivered to the Optionee at the address then
appearing on the records of the Company. Such addresses may be changed at any
time by notice from one party to the other. Notices given hereunder shall be in
writing, and shall be deemed to have been duly given upon delivery thereof, if
personally delivered, or three days after being deposited in the United States
mail, registered or certified mail, properly addressed, with proper postage and
fees prepaid, or one day after being deposited with a delivery service
guaranteeing overnight delivery, properly addressed, with fees paid by the
sender.

      13. Binding Effect. This agreement shall be binding upon and inure to the
benefit of the parties hereto, including the successors and assigns of the
Company and the heirs and personal representatives of the Optionee.

                                      -5-

<PAGE>

      IN WITNESS WHEREOF, the Company has granted this Option as of the day and
year first above written.

                                          OSI PHARMACEUTICALS, INC.
                                          ________________________________
                                          Name: Robert L. Van Nostrand
                                          Title: Vice President and
                                                 Chief Financial Officer

                                          ACCEPTED BY (OPTIONEE):
                                          ________________________________
                                          Name: {FIRST NAME LAST NAME}

                                          ________________________________
                                          Date

                                       -6-<PAGE>
                                                                    EXHIBIT 10.7

              Compensatory Arrangements for Non-Employee Directors
              ----------------------------------------------------

Annual Retainer Fee:
-------------------

       OSI Pharmaceuticals, Inc. ("OSI" or the "Company") compensates its
non-employee directors for service on the Board of Directors. Effective January
1, 2003, each non-employee director is paid an annual retainer fee of $50,000.
The Chairman of the Board and the Chair of the Audit Committee are paid an
additional annual retainer fee of $100,000 and $40,000, respectively, in
recognition of their increased responsibility and service. Each other
non-employee director who serves as a member of the Audit Committee is paid an
additional annual retainer fee of $25,000, and each non-employee director who
serves as a member of any other Board committee, but is not a member of the
Audit Committee, is paid an additional annual retainer fee of $12,500.

       Fifty-percent of the annual retainer fee earned by each non-employee
director is provided to the director in the form of a restricted stock award
under the terms of the Stock Purchase Plan for Non-Employee Directors (the
"Stock Purchase Plan") or the Amended and Restated Stock Incentive Plan ("Stock
Incentive Plan"). The remaining fifty-percent of the director's annual retainer
is payable in equal monthly installments in cash, or at the election of the
director, in restricted stock under the Stock Purchase Plan or the Stock
Incentive Plan. Restricted stock awards are made as of each annual stockholder
meeting at which directors are elected beginning with the meeting that occurred
on March 19, 2003 or upon a director's initial election to the Board. The number
of shares of the restricted stock awards is based on the price of the common
stock on the date of grant. Annual restricted stock awards vest in monthly
installments over the one-year term for which the award is made. In the event a
director's membership on the Board terminates prior to the end of such term, any
unvested portion of the director's restricted stock award is forfeited. Shares
of restricted stock awarded annually may not be sold or transferred by the
director until the first anniversary of the date of grant.

Formula Option Grants:
---------------------

       Each non-employee director is entitled to an automatic, formula-based
grant of non-qualified stock options for shares of OSI common stock pursuant to
the Company's Amended and Restated Stock Incentive Plan. Each non-employee
director receives an initial grant of options upon his or her initial election
to the Board. Each individual who becomes a director on or after January 1, 2003
receives an initial option to purchase 50,000 shares of common stock upon his or
her initial election to the Board. Individuals who became a director after June
30, 2001 but prior to January 1, 2003, received an initial option to purchase
30,000 shares of common stock. The Chairman of the Board receives an additional
option to purchase 50,000 shares of common stock upon initial election as
Chairman.

       In addition to initial option awards, the Stock Incentive Plan provides
for the annual grant of non-qualified options to non-employee directors.
Individuals who first became directors prior to June 13, 2001 receive annual
option awards as follows:

<PAGE>

                        Schedule of Annual Option Awards
                        --------------------------------
<TABLE>

 Number of Shares
   Underlying
 Annual Option
    Awards                               Timing of Awards
-----------------                        ----------------
<CAPTION>
<S>              <C>

    20,000       On the date of the Non-Employee Director's reelection to a third one-year term;
    20,000       On the date of the Non-Employee Director "s reelection to a fourth one-year term;
    15,000       On the date of the Non-Employee Director's reelection to a fifth one-year term;
    15,000       On the date of the Non-Employee Director's reelection to a sixth one-year term;
    10,000       On the date of the Non-Employee Director's reelection to a seventh one-year term;
    10,000       On the date of the Non-Employee Director's reelection to an eighth one-year term;
    10,000       On the date of the Non-Employee Director's reelection to a ninth one-year term; and
     7,500       On the date of the Non-Employee Director's reelection to each one-year term thereafter.

</TABLE>

       Individuals who first become non-employee directors after June 13, 2001
receive an annual option award to purchase 7,500 shares of common stock upon
each reelection for a one-year Board term, with the exception of the Chairman of
the Board. The Chairman of the Board receives 15,000 shares of common stock upon
reelection for a one-year Board term.

       Initial option awards granted prior to January 1, 2003 vested one-half
immediately upon grant and one-half upon the director's re-election to the Board
for a second consecutive term. All initial option awards granted on and after
January 1, 2003 and all annual option awards vest one-third upon the first
anniversary of their date of grant, with the remainder vesting ratably on a
monthly basis over the succeeding 24 months. The exercise price of all option
awards is equal to 100% of the fair market value of the common stock on the date
of grant. All option awards expire on the tenth anniversary of their respective
grant dates, subject to the sooner expiration upon the occurrence of certain
events set forth under the terms of the Stock Incentive Plan.

                                      -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]